Downstream Processing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Downstream process is the part of a bioprocess that include the recovery and purification of biosynthetic products. The biosynthetic products include pharmaceutical products, mainly from the natural sources such as animal tissues, plant tissues or fermentation broth. The downstream process is an essential part in the manufacturing of vaccines, antibodies, antibiotics and hormones, such as insulin and humans growth hormone. The process include filtration, solid-liquid separation and chromatography techniques that are used for quality requirements including formulation and purification.

MARKET SCOPE

The "Global Downstream Processing Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the downstream processing market with detailed market segmentation by product, technology, application, end users, and geography. The report provides key statistics on the market status of the leading downstream processing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

• Based on product, the global downstream processing market is segmented into chromatography columns and resins, filters, membrane adsorbers, single-use products and others.
• Based on technology, the market is bifurcated into purification techniques, solid-liquid separation and clarification/concentration.
• Based on product, the global downstream processing market is segmented into monoclonal antibody production, vaccines production, insulin production, immunoglobulin production, erythropoietin production and others.
• Based on technology, the market is bifurcated into biopharmaceutical manufacturers and contract manufacturing organizations.

MARKET DYNAMICS

Drivers

• Rising R&D expenditure for biopharmaceutical companies
• Increasing demand for biopharmaceuticals.

Restraints

• Patent expiration of the popular biopharmaceuticals

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The downstream processing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the downstream processing market in these regions.

IMPACT OF COVID-19 ON DOWNSTREAM PROCESSING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19.

MARKET PLAYERS

The report covers key developments in the downstream processing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from downstream processing market are anticipated to lucrative growth opportunities in the future with the rising demand for downstream processing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the downstream processing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• Thermo Fisher Scientific Inc.
• GENERAL ELECTRIC COMPANY
• Merck KGaA
• Danaher
• 3M
• Repligen Corporation.
• Lonza
• Eppendorf AG
• Corning Incorporated
• Sartorius AG

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Downstream Processing Report Scope